05:07 PM EDT, 03/24/2026 (MT Newswires) -- TELA Bio ( TELA ) reported a Q4 net loss Tuesday of $0.17 per diluted share, narrowing from the loss of $0.23 a year earlier.

One analyst polled by FactSet expected a loss of $0.19.

Revenue in the three months ended Dec. 31 rose to $20.9 million from $17.6 million a year earlier.

Analysts surveyed by FactSet expected $21 million.

The company expects Q1 revenue of $18.5 million.

Four analysts polled by FactSet project $21.3 million.